SOF/VEL for 12 weeks is well tolerated and results in high SVR12 rates in people receiving opioid substitution therapy

Details

Database :

OAIster

Notes :

English

Publication Type :

Electronic Resource

Accession number :

edsoai.on1031074305

Document Type :

Electronic Resource